1.305
전일 마감가:
$1.28
열려 있는:
$1.29
하루 거래량:
338.08K
Relative Volume:
0.20
시가총액:
$238.31M
수익:
$137.74M
순이익/손실:
$-27.97M
주가수익비율:
-8.1563
EPS:
-0.16
순현금흐름:
$-9.61M
1주 성능:
-2.61%
1개월 성능:
+3.57%
6개월 성능:
-31.68%
1년 성능:
-29.08%
Heron Therapeutics Inc Stock (HRTX) Company Profile
명칭
Heron Therapeutics Inc
전화
(858) 251-4400
주소
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
HRTX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
HRTX
Heron Therapeutics Inc
|
1.30 | 234.64M | 137.74M | -27.97M | -9.61M | -0.16 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.18 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
471.48 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
552.36 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
808.25 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-06-09 | 개시 | H.C. Wainwright | Buy |
2024-06-13 | 개시 | Rodman & Renshaw | Buy |
2024-04-23 | 개시 | CapitalOne | Overweight |
2024-03-13 | 재확인 | Needham | Buy |
2020-05-27 | 개시 | Guggenheim | Buy |
2020-02-20 | 재확인 | Needham | Buy |
2019-01-16 | 재확인 | Needham | Buy |
2018-04-05 | 개시 | Evercore ISI | Outperform |
2018-03-19 | 재확인 | Mizuho | Buy |
2018-03-01 | 재확인 | Needham | Buy |
2018-01-03 | 개시 | Leerink Partners | Outperform |
2017-09-27 | 개시 | Northland Capital | Outperform |
2017-02-27 | 개시 | Needham | Buy |
2016-10-26 | 개시 | Aegis Capital | Buy |
2016-09-06 | 재개 | Lake Street | Buy |
2016-05-03 | 개시 | Cantor Fitzgerald | Buy |
2015-12-10 | 개시 | Lake Street | Buy |
2015-09-23 | 재확인 | Leerink Partners | Outperform |
2015-09-02 | 개시 | BofA/Merrill | Buy |
2015-08-03 | 재확인 | Brean Capital | Buy |
2015-06-30 | 재확인 | JMP Securities | Mkt Outperform |
2015-06-19 | 재확인 | Leerink Partners | Outperform |
2014-08-07 | 개시 | Noble Financial | Buy |
모두보기
Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스
Published on: 2025-10-13 09:46:10 - newser.com
Why Heron Therapeutics Inc. stock could benefit from AI revolutionQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - newser.com
Can Heron Therapeutics Inc. stock weather global recessionMarket Risk Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Building trade automation scripts for Heron Therapeutics Inc.Quarterly Market Summary & Verified Momentum Stock Alerts - newser.com
Heron Therapeutics Inc. stock prediction for this weekQuarterly Performance Summary & Technical Buy Zone Confirmation - newser.com
Cyndeo Wealth Partners LLC Takes Position in Heron Therapeutics, Inc. $HRTX - MarketBeat
Is Heron Therapeutics Inc AXD2 a good long term investment - earlytimes.in
Heron Therapeutics (NASDAQ:HRTX) Upgraded at Zacks Research - Defense World
Heron Therapeutics (NASDAQ:HRTX) Stock Rating Upgraded by Zacks Research - MarketBeat
Chart based analysis of Heron Therapeutics Inc. trendsBear Alert & Momentum Based Trading Signals - newser.com
How Heron Therapeutics Inc. (AXD2) stock reacts to stronger dollarMarket Sentiment Report & Real-Time Buy Signal Notifications - newser.com
Heron Therapeutics (NASDAQ:HRTX) Earns "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Why Heron Therapeutics Inc. is moving today2025 Trade Ideas & Fast Entry Momentum Trade Alerts - newser.com
Heron Therapeutics Inc. stock retracement – recovery analysisTrade Exit Summary & Entry Point Confirmation Alerts - newser.com
Is Heron Therapeutics Inc. stock positioned well for digital economyShort Setup & Smart Money Movement Alerts - newser.com
Why Heron Therapeutics Inc. stock remains on buy lists2025 AllTime Highs & Verified Short-Term Plans - newser.com
What data driven models say about Heron Therapeutics Inc.’s future - newser.com
Why Heron Therapeutics Inc. (AXD2) stock could be top winnerChart Signals & Smart Money Movement Tracker - newser.com
Published on: 2025-10-01 09:34:43 - newser.com
Chart overlay techniques for tracking Heron Therapeutics Inc.Trade Analysis Summary & Reliable Price Breakout Alerts - newser.com
Why Heron Therapeutics Inc. (AXD2) stock signals breakout potentialJuly 2025 Earnings & Consistent Growth Equity Picks - newser.com
What analysts say about Heron Therapeutics Inc AXD2 stockFundamental Strength Indicators & Free Hedging Tactics for Volatile Markets - Early Times
Is Heron Therapeutics Inc a good long term investmentSector Rotation Strategies & Free Dynamic Capital Growth - Early Times
Heron Therapeutics Strengthens Financial Position with Refinancing - MSN
Heron Therapeutics, Inc. $HRTX Shares Acquired by Congress Park Capital LLC - MarketBeat
Heron Therapeutics Inc (HRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Heron Therapeutics Inc 주식 (HRTX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Morgan Adam | Director |
Aug 08 '25 |
Buy |
1.50 |
1,766,546 |
2,649,819 |
8,753,290 |
자본화:
|
볼륨(24시간):